David Gobel
Director/Miembro de la Junta en ORGANOVO HOLDINGS, INC. .
Fortuna: 19 372 $ al 30/04/2024
Cargos activos de David Gobel
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ORGANOVO HOLDINGS, INC. | Director/Miembro de la Junta | 15/09/2020 | - |
| Independent Dir/Board Member | 15/09/2020 | - | |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Director/Miembro de la Junta | 01/12/2014 | - |
| Independent Dir/Board Member | 01/12/2014 | - | |
Methuselah Capital Management LLC
 Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Director Ejecutivo | 01/01/2017 | - |
| Fundador | 01/01/2017 | - | |
Leucadia Therapeutics, Inc.
 Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware. | Director/Miembro de la Junta | 01/10/2015 | - |
| Methuselah Foundation | Director Ejecutivo | 01/09/2001 | - |
| Fundador | 01/09/2001 | - | |
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Presidente | 01/05/2020 | - |
| Director/Miembro de la Junta | 01/07/2018 | 01/05/2020 |
Historial de carrera de David Gobel
Antiguos cargos conocidos de David Gobel.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Volumetric Biotechnologies, Inc. | Director/Miembro de la Junta | 01/04/2018 | 01/01/2020 |
| Transportation Security Administration | Corporate Officer/Principal | 01/01/2009 | 01/03/2013 |
Estadísticas
Internacional
| Estados Unidos | 9 |
Operativa
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorial
| Health Technology | 5 |
| Government | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ORGANOVO HOLDINGS, INC. | Health Technology |
| Empresas privadas | 7 |
|---|---|
| Transportation Security Administration | Government |
| Methuselah Foundation | |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Health Technology |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Finance |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware. | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Health Technology |
| Volumetric Biotechnologies, Inc. |
- Bolsa de valores
- Insiders
- David Gobel
- Experiencia
